Mungipa Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 103.90%
- Net Worth 0.60%
- Total Assets -38.05%
About Mungipa Pharmaceuticals
Mungipa Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 June 2013 and has a history of 11 years and eight months. Its registered office is in Darjiling, West Bengal, India.
The Corporate was formerly known as Mangaldham Marketing Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pritam Agarwal and Kamlesh Agarwal serve as directors at the Company.
Company Details
- Location
Darjiling, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900WB2013PTC194226
- Company No.
194226
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jun 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Mungipa Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pritam Agarwal  | Director | 15-Oct-2014 | Current |
| Kamlesh Agarwal | Director | 03-Apr-2019 | Current |
Financial Performance of Mungipa Pharmaceuticals.
Mungipa Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 103.9% increase in profit. The company's net worth moved up by a moderate rise of 0.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mungipa Pharmaceuticals?
Unlock access to Mungipa Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Mla Krk Infra Realty LlpPritam Agarwal is a mutual person
- Lemongrass Organic Tea Estates Private Limited
Pritam Agarwal is a mutual person
- Sati Trade Agency Private Limited
Pritam Agarwal is a mutual person
- Albatross Distributors Private Limited
Pritam Agarwal is a mutual person
- Panchmahal Real Estate Private Limited
Pritam Agarwal is a mutual person
- Nirmala Powertech Private Limited
Pritam Agarwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mungipa Pharmaceuticals?
Unlock and access historical data on people associated with Mungipa Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mungipa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mungipa Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
